UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients

European journal of cancer (1990), 2015-09, Vol.51, p.S456-S457

2015

Link zum Volltext

Verfügbarkeit prüfen

2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?

European journal of cancer (1990), 2015-09, Vol.51, p.S460-S461

2015

Link zum Volltext

Verfügbarkeit prüfen

652PEGFR AND AKT1 OVEREXPRESSION ARE MUTUALLY EXCLUSIVE AND ASSOCIATED WITH A POOR SURVIVAL IN RESECTED ADENOCARCINOMAS OF THE STOMACH AND GASTRO-ESOPHAGEAL JUNCTION

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv223-iv223

2014

Link zum Volltext

Verfügbarkeit prüfen

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Future oncology (London, England), 2013-02, Vol.9 (2), p.283-294

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for resected biliary tract cancer: A retrospective analysis

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14614-e14614

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

European journal of surgical oncology, 2013-04, Vol.39 (4), p.396-403

2013

Link zum Volltext

Verfügbarkeit prüfen

Canakinumab for the treatment of TNF-receptor associated periodic syndrome

Expert review of clinical immunology, 2017-06, Vol.13 (6), p.513-523

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of advanced gastric cancer patients treated with at least three lines of chemotherapy: analysis on 300 Italian real-world cases

Annals of oncology, 2016-09, Vol.27, p.iv19

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac)

HPB (Oxford, England), 2016-04, Vol.18, p.e43-e44

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

HPB (Oxford, England), 2019, Vol.21, p.S760-S760

2019

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

HPB (Oxford, England), 2019, Vol.21, p.S1019-S1020

2019

Link zum Volltext

Verfügbarkeit prüfen

Concomitant versus sequential treatment with TACE and sorafenib in HCC patients

Digestive and liver disease, 2014-02, Vol.46, p.e37-e37

2014

Link zum Volltext

Verfügbarkeit prüfen

Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer

Annals of oncology, 2017-10, Vol.28, p.vi47-vi47

2017

Link zum Volltext

Verfügbarkeit prüfen

Egfr and Akt1 Overexpression are Mutually Exclusive and Associated with a Poor Survival in Resected Adenocarcinomas of the Stomach and Gastro-Esophageal Junction

Annals of oncology, 2014-09, Vol.25, p.iv223

2014

Link zum Volltext

Verfügbarkeit prüfen

Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments

Clinical and experimental rheumatology, 2018-09, Vol.36 (5), p.929

2018

Link zum Volltext

Verfügbarkeit prüfen

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

British journal of cancer, 2013-06, Vol.108 (12), p.2549-2556

2013

Link zum Volltext

Verfügbarkeit prüfen

Histopathologic response to FOLFOXIRI plus bevacizumab of liver metastases from colorectal cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14012-e14012

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification of responders to sorafenib in hepatocellular carcinoma: Is tumour volume measurement the way forward?

Digestive and liver disease, 2013-10, Vol.45, p.e370-e370

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of age, ECOG PS and type of treatment on progression-free survival and overall survival in second-line therapy for advanced gastric cancer: analysis on 709 cases

Annals of oncology, 2015-10, Vol.26, p.vi91

2015

Link zum Volltext

Verfügbarkeit prüfen

Local specific immunotherapy in allergic conjunctivitis

Acta ophthalmologica, 1994-10, Vol.72 (5), p.631-634

1994

Link zum Volltext

Verfügbarkeit prüfen

Local specific immunotherapy in allergic conjunctivitis

Acta ophthalmologica (Oxford, England), 1994-10, Vol.72 (5), p.631-634

1994

Link zum Volltext

Verfügbarkeit prüfen

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

OncoTargets and therapy, 2016-01, Vol.9, p.6065-6074

2016

Link zum Volltext

Verfügbarkeit prüfen

Not only chemotherapy in the second-line treatment of metastatic gastric cancer

Annals of oncology, 2014-02, Vol.25 (2), p.544-545

2014

Link zum Volltext

Verfügbarkeit prüfen

OC1.10.3 COMPUTER SIMULATOR AND EXPERT COLONOSCOPISTS. IS INFORMATION USEFUL?

Digestive and liver disease, 2008, Vol.40, p.S30-S30

2008

Link zum Volltext

Verfügbarkeit prüfen

P-147 Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?

Annals of oncology, 2015-06, Vol.26, p.iv42

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Female
(9)
Male
(8)
Gastroenterology And Hepatology
(7)
Adult
(6)
Middle Aged
(6)
Oncology
(6)
Aged
(5)
Retrospective Studies
(4)
Aged, 80 And Over
(3)
Biological And Medical Sciences
(3)
Child
(3)
Gastroenterology & Hepatology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Italy
(3)
Medical Sciences
(3)
Camptothecin - Analogs & Derivatives
(2)
Cancer Therapies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients

2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?

652PEGFR AND AKT1 OVEREXPRESSION ARE MUTUALLY EXCLUSIVE AND ASSOCIATED WITH A POOR SURVIVAL IN RESECTED ADENOCARCINOMAS OF THE STOMACH AND GASTRO-ESOPHAGEAL JUNCTION

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Adjuvant chemotherapy for resected biliary tract cancer: A retrospective analysis

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

Canakinumab for the treatment of TNF-receptor associated periodic syndrome

Characteristics and outcomes of advanced gastric cancer patients treated with at least three lines of chemotherapy: analysis on 300 Italian real-world cases

Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac)

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

Concomitant versus sequential treatment with TACE and sorafenib in HCC patients

Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer

Egfr and Akt1 Overexpression are Mutually Exclusive and Associated with a Poor Survival in Resected Adenocarcinomas of the Stomach and Gastro-Esophageal Junction

Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

Histopathologic response to FOLFOXIRI plus bevacizumab of liver metastases from colorectal cancer

Identification of responders to sorafenib in hepatocellular carcinoma: Is tumour volume measurement the way forward?

Impact of age, ECOG PS and type of treatment on progression-free survival and overall survival in second-line therapy for advanced gastric cancer: analysis on 709 cases

Local specific immunotherapy in allergic conjunctivitis

Local specific immunotherapy in allergic conjunctivitis

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Not only chemotherapy in the second-line treatment of metastatic gastric cancer

OC1.10.3 COMPUTER SIMULATOR AND EXPERT COLONOSCOPISTS. IS INFORMATION USEFUL?

P-147 Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?

Suchergebnisse filtern